News Image

Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

Provided By GlobeNewswire

Last update: Nov 24, 2025

Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

Read more at globenewswire.com

CERIBELL INC

NASDAQ:CBLL (11/26/2025, 8:19:27 PM)

After market: 16.91 0 (0%)

16.91

-0.44 (-2.54%)


Find more stocks in the Stock Screener

Follow ChartMill for more